Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development
- PMID: 29165651
- DOI: 10.1093/infdis/jix583
Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development
Abstract
Plasmodium vivax and P. falciparum malaria species have diverged significantly in receptor-ligand interactions and host-cell invasion. One protein common to both is the merozoite invasion ligand AMA1. While the general structure of AMA1 is similar between species, their sequences are divergent. Surprisingly, it was possible to genetically replace PfAMA1 with PvAMA1 in P. falciparum parasites. PvAMA1 complemented PfAMA1 function and supported invasion of erythrocytes by P. falciparum. Genetically modified P. falciparum expressing PvAMA1 evaded the invasion inhibitory effects of antibodies to PfAMA1, demonstrating species specificity of functional antibodies. We generated antibodies to recombinant PvAMA1 that effectively inhibited invasion, confirming the function of PvAMA1 in genetically modified parasites. Results indicate significant molecular flexibility in AMA1 enabling conserved function despite substantial sequence divergence across species. This provides powerful new tools to quantify the inhibitory activities of antibodies or drugs targeting PvAMA1, opening new opportunities for vaccine and therapeutic development against P. vivax.
Keywords: AMA1; Plasmodium; malaria; merozoite; vaccine.
© The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission.Malar J. 2014 Jun 14;13:233. doi: 10.1186/1475-2875-13-233. Malar J. 2014. PMID: 24930015 Free PMC article.
-
ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency.PLoS One. 2008;3(10):e3366. doi: 10.1371/journal.pone.0003366. Epub 2008 Oct 10. PLoS One. 2008. PMID: 18846221 Free PMC article.
-
A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.Vaccine. 2024 Mar 7;42(7):1785-1792. doi: 10.1016/j.vaccine.2024.02.029. Epub 2024 Feb 16. Vaccine. 2024. PMID: 38365484
-
Apical membrane antigen 1 as an anti-malarial drug target.Curr Top Med Chem. 2011;11(16):2039-47. doi: 10.2174/156802611796575885. Curr Top Med Chem. 2011. PMID: 21619512 Review.
-
Invasion of erythrocytes by malaria parasites: a cellular and molecular overview.Annu Rev Microbiol. 1986;40:451-77. doi: 10.1146/annurev.mi.40.100186.002315. Annu Rev Microbiol. 1986. PMID: 3535649 Review.
Cited by
-
Molecular Assessment of Domain I of Apical Membrane Antigen I Gene in Plasmodium falciparum: Implications in Plasmodium Invasion, Taxonomy, Vaccine Development, and Drug Discovery.Can J Infect Dis Med Microbiol. 2022 Oct 7;2022:1419998. doi: 10.1155/2022/1419998. eCollection 2022. Can J Infect Dis Med Microbiol. 2022. PMID: 36249587 Free PMC article.
-
Identification, Mapping, and Genetic Diversity of Novel Conserved Cross-Species Epitopes of RhopH2 in Plasmodium knowlesi With Plasmodium vivax.Front Cell Infect Microbiol. 2022 Jan 13;11:810398. doi: 10.3389/fcimb.2021.810398. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35096656 Free PMC article.
-
Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity.Front Cell Infect Microbiol. 2022 Aug 9;12:950909. doi: 10.3389/fcimb.2022.950909. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36017364 Free PMC article.
-
Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines.Cell Mol Life Sci. 2023 Feb 27;80(3):74. doi: 10.1007/s00018-023-04712-z. Cell Mol Life Sci. 2023. PMID: 36847896 Free PMC article.
-
The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design.Front Immunol. 2020 Feb 27;11:335. doi: 10.3389/fimmu.2020.00335. eCollection 2020. Front Immunol. 2020. PMID: 32174924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources